Early Response to Ranibizumab Is Associated with 12-Month Outcome in Diabetic Macular Edema after Prior Macular Laser Therapy

Publisher： Karger

E-ISSN： 1423-0267|238|3|139-146

ISSN： 0030-3755

Source： Ophthalmologica, Vol.238, Iss.3, 2017-07, pp. : 139-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema

By  

Case Reports in Ophthalmology, Vol. 6, Iss. 1, 2015-02 ,pp. : 44-50

Karger

Access to resources Recommend Favorite

Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema

By  

Ophthalmologica, Vol. 232, Iss. 3, 2014-08 ,pp. : 136-143

Karger

Access to resources Recommend Favorite

Long-Term Outcome after Vitrectomy for Diabetic Macular Edema

By  

Ophthalmologica, Vol. 220, Iss. 3, 2006-05 ,pp. : 147-152

Karger

Access to resources Recommend Favorite

Degree of Decrease in Central Retinal Thickness Predicts Visual Acuity Response to Intravitreal Ranibizumab in Diabetic Macular Edema

By  

Ophthalmologica, Vol. 231, Iss. 1, 2013-11 ,pp. : 16-22

Karger

Access to resources Recommend Favorite

Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting

By  

Ophthalmologica, Vol. 236, Iss. 4, 2016-11 ,pp. : 207-214

Karger

Access to resources Recommend Favorite